Microbot Medical Inc. reported the issuance of 1,480,504 shares through the exercise of Series E and F options, raising approximately $2.22 million since May 13, 2025. The company also announced the granting of a patent in China for robotic manipulation of surgical tools, a significant step in its global IP strategy.